References
- Lavker R, Gerberick G, Veres D, Irwin C, Kaidbey K. Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin. J. Am. Acad. Dermatol.32, 53–62 (1995).
- Lavker RM, Kaidbey K. The spectral dependence for UVA-induced cumulative damage in human skin. J. Invest. Dermatol.108, 17–21 (1997).
- Lowe NJ, Meyers DP, Wieder JM et al. Low doses of repetitive ultraviolet A induce morphologic changes in human skin. J. Invest. Dermatol.105, 739–743 (1995).
- Séité S, Moyal D, Richard S et al. Effects of repeated suberythemal doses of UVA in human skin. Eur. J. Dermatol.7, 204–209 (1997).
- Kuchel J, Barnetson R, Halliday G. Ultraviolet A augments solar-simulated ultraviolet radiation-induced local suppression of recall responses in humans. J. Invest. Dermatol.118, 1032–1037 (2002).
- Garland CF, Garland FC, Gorham EC. Epidemiologic evidence for different roles of ultraviolet A and B radiation in melanoma mortality rates. Ann. Epidemiol.13, 395–404 (2003).
- Agar NS, Halliday GM, Barnetson RS et al. The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc. Natl Acad. Sci. USA101, 4954–4959 (2004).
- Séité S, Moyal D, Richard S et al. Mexoryl SX: a broadspectrum absorption UVA filter protects human skin from the effects of repeated suberythemal doses of UVA. J. Photochem. Photobiol. B Biol.44, 69–76 (1998).
- Tuchinda C, Lim HW, Osterwalder U, Rougier A. Novel emerging sunscreen technologies. Dermatol. Clin.24(1), 105–117 (2006).
- Moyal D, Fourtanier A. Broadspectrum sunscreens provide better protection from the suppression of the elicitation phase of delayed-type hypersensitivity response in humans. J. Invest. Dermatol.117, 1186–1192 (2001).
- Fourtanier A, Bernerd F, Bouillon C, Marrot L, Moyal D, Seité S. Protection of skin biological targets by different types of sunscreens. Photodermatol. Photoimmunol. Photomed.22, 22–32 (2006).
- Damian DL, Halliday GM, Barnetson RSC. Broadspectrum sunscreens provide greater protection against ultraviolet-radiation-induced suppression of contact hypersensitivity to a recall antigen in humans. J. Invest. Dermatol.109, 146–151 (1997).
- Stanfield J, Edmonds S, Agin P. An evaluation of methods for measuring sunscreen ultraviolet A protection factors. In: Sunscreens: Development, Evaluation and Regulatory Aspects. Lowe NJ, Shaath NA, Pathak MA (Eds). Marcel Dekker Inc., NY, USA 537–558 (1997).
- Chardon A, Moyal D, Hourseau C. Persistent pigment darkening response for evaluation of ultraviolet A protection assays. In: Sunscreens: Development, Evaluation and Regulatory Aspects. Lowe N, Shaath N, Pathak M (Eds). Marcel Dekker Inc., NY, USA 559–582 (1997).
- Moyal D, Chardon A, Kollias N. UVA protection efficacy of sunscreens can be determined by the persistent pigment darkening (PPD) method (part 2). Photodermatol. Photoimmunol. Photomed.16, 250–255 (2000).
- Kollias N, Bykowski JL. Immediate pigment darkening threshold of human skin to monochromatic (362 nm) ultraviolet A radiation are fluence rate dependent. Photodermatol. Photoimmunol. Photomed.15, 175–178 (1999).
- Cole C. Sunscreen protection in the ultraviolet A region: how to measure the effectiveness. Photodermatol. Photoimmunol. Photomed.17, 2–10 (2001).
- Moyal D, Wichrowski K, Tricaud C. In vivo persistent pigment darkening method: a demonstration of the reproducibility of the UVA protection factors results at several testing laboratories. Photodermatol. Photoimmunol. Photomed.22, 124–128 (2006).
- Moyal D, Pissavini M, Boyer F, Perier V, Frêlon JH. In vivo persistent pigment darkening method: proposal of a new standard product for UVA protection factor determination. Intern. J. Cosm. Sci.29, 443–449 (2007).
- Maier H, Schauberger G, Martincigh BS, Brunnhofer K, Hönigsmann H. Ultraviolet protective performance of photoprotective lipsticks: change of spectral transmittance because of ultraviolet exposure. Photodermatol. Photoimmunol. Photomed.21(2), 84–92 (2005).
- Moyal D, Refrégier JL, Chardon A. In vivo measurement of the photostability of sunscreen products using diffuse reflectance spectroscopy. Photodermatol. Photoimmunol. Photomed.18, 14–22 (2002).
- Sayre R, Agin P, LeVee J, Marlowe E. A comparison of in vivo and in vitro testing of sunscreening formulas. Photochem. Photobiol.29, 556–566 (1979).
- Diffey B, Robson, J. A new substrate to measure sunscreen protection factors throughout the ultraviolet spectrum. J. Soc. Cosm. Chem.40, 123–133 (1989).
- Ferrero L, Pissavini M, Dehais A, Marguerie S, Zastrow L. Importance of substrate roughness for in vitro sun protection assessment. IFSCC magazine (Vol. 9), N2 (2006)
- Diffey BL. A method for broadspectrum classification of sunscreens. Int. J. Cosmet. Sci.16, 47–52 (1994).
- Boots the Chemist Ltd. The revised guidelines to the practical measurement of UVA/UVB ratios according to the Boots star rating system. The Boots Co. PLC, Notthingham, UK (2004).
- Forestier S. Pitfalls in the in vitro determination of critical wavelength using absorbance curves. SÖFW J.125, 8–9 (1999).
- Rudolph T. UVA protection assessment of sunscreens: a critical review on the UVA-to-UVB absorbance ratio. SÖFW J.130, 28–35 (2004).
- Diffey BL, Tanner PR, Matts PJ, Nash JF. In vitro assessment of the broadspectrum ultraviolet protection of sunscreen products. J. Am. Acad. Dermatol.43, 1024–1035 (2000).
- Wendel V, Klette E, Gers-Barlag H. A new in vitro test method to assess the UVA protection performance of sun care products. SÖFW J.127, 12–31 (2001).
Websites
- JCIA: Japan Cosmetic Industry Association measurement standard for UVA protection efficacy (1995) www.jcia.org
- Korean FDA. Korean Measurement standards for UV protection efficacy (2004) www.kfda.go.kr
- Hygienic standard for cosmetics, MOH, China. UVA protection factor test method of cosmetic sunscreens (2007) www.moh.gov.cn/newshtml/17481.htm
- European Commission recommendation on the efficacy of sunscreen products and the claims made relating thereto OJL 265/39 (2006) http://eur-lex.europa.eu/JOHtml.do?uri=OJ:L:2006:265:SOM:EN:HTML
- Department of Health and Human services. FDA. 21 CFR parts 347–352. Sunscreen drug Products for OTC human use; proposed amendment of final monograph; proposed rule (2007) www.fda.gov/OHRMS/DOCKETS/98fr/07-4131.pdf
- Australian/New Zealand standard. Sunscreen products – evaluation and classification. AS/NZS 2604 (1998) www.standards.com.au
- DIN 67502. Characterization of UVA protection of dermal suncare products by measuring the transmittance with regard to the sun-protection factor (2004) www.din.de
- Colipa guidelines. Method for the in vitro determination of UVA protection provided by sunscreen products (2007) www.colipa.be